Publications du Docteur OUZZANE

Cliquez sur les titres pour dérouler la liste des articles

- P Colin, P Koenig, A Ouzzane, N Berthon, A Villers, J Biserte, M Rouprêt : Environemental factors involved in carcinogenesis of urothelial cell carcinomas of the upper urinary tract. BJU int. 2009 Nov; 104(10):1436-40.

- A Villers, A Ouzzane : Word of wisdom. Re: three-dimensional prostate mapping biopsy has a potentially significant impact on prostate cancer management. Eur Urol. 2010 Dec;58(6):941-2.

- A Ouzzane, TP Ghoneim, K Udo, M Verhasselt-Crinquette, P Puech, N Betrouni, M Rouprêt, A Villers, X Leroy, P Colin : Small cell carcinoma of the Upper Urinary Tract (UUT-SCC): Report of a rare entity and systematic review of the literature. Cancer Treat Rev. 2011 Aug;37(5):366-72.

- A Ouzzane, P Colin, E Xylinas, G Pignot, MM Ariane, F Saint, N Hoarau, E Adam, MD Azemar, H Bensadoun, L Cormier, O Cussenot, A Houlgatte, G Karsenty, F Bruyère, C Maurin, FX Nouhaud, V Phe, T Polguer, M Roumiguié, A Ruffion, M Rouprêt : Ureteral and Multifocal Tumours Have Worse Prognosis than Renal Pelvic Tumours in Urothelial Carcinoma of the Upper Urinary Tract Treated by Nephroureterectomy. Eur Urol 2011 Dec;60(6):1258-65.

- M Vassilakopoulou, T de la Motte Rouge, P Colin, A Ouzzane, MM Ariane, D Khayat, MA Dimopoulos, CA Papadimitriou, A Bamias, G Pignot, FX Nouhaud, S Hurel, L Guy, P Bigot, M Roumiguié, M Rouprêt : Outcomes after adjuvant chemotherapy in the treatment of high-risk urothelial cell carcinoma of the upper urinary tract (UUT-UCC): results from a large multicentre collaborative study. Cancer 2011 Dec 15;117(24):5500-8.

- MM Ariane, P Colin, A Ouzzane, G Pignot, M Audouin, JN Cornu, FX Nouhaud, J Guillotreau, Y Neuzillet, E Adam, S Hurel, AR Azzouzi, F Staerman, G Karsenty, F Arroua, A De la Taille, E Ravier, A Matte, F Bruyère, M Rouprêt : Assessment of oncologic control obtained after open versus laparoscopic nephroureterectomy for upper urinary tract urothelial cell carcinomas (UUT-UCCs): results from a large french multicenter collaborative study. Ann Surg Oncol 2012 Jan;19(1):301-8.

- G Ploussard, A Masson-Lecomte, JB Beauval, A Ouzzane, R Bonniol, F Buge, S Fadli, M Rouprêt, X Rebillard, N Gaschignard, C Pfister, A Villers, M Soulié, L Salomon : Radical Prostatectomy for High-risk Prostate Cancer Defined by Preoperative Criteria: Oncologic Follow-up in National Multicenter Study in 813 Patients and Assessment of Easy-to-use Prognostic Substratification. Urology 2011 Sep;78(3):607-13.

- A Ouzzane, P Puech, L Lemaitre, X Leroy, P Nevoux, N Betrouni, GP Haber, A Villers : Combined Multiparametric MRI and Targeted Biopsies Improve Anterior Prostate Cancer Detection, Staging and Grading. Urology 2011 Dec;78(6):1356-62.

- P Nevoux, A Ouzzane, X Leroy, HU Ahmed, M Emberton, R Montironi, JC Presti, A Villers : Quantitative tissue analyses of prostate cancer foci in an unselected cystoprostatectomy series. BJU int 2011 Aug;110(4):517-23.

- A Ouzzane, P Puech, A Villers : MRI and Surveillance. Curr Opin Urol. 2012 May;22(3):231-6.

- P Colin, A Ouzzane, DR Yates, A François, G Pignot, A Arvin-Berod, O Merigot de Treigny, G Laurent, A Valeri, I Jacques, F Saint, S Gardic, P Gres, F Rozet, Y Neuzillet, A Ruffion, M Rouprêt : Influence of Positive Surgical Margin Status After Radical Nephroureterectomy on Upper Urinary Tract Urothelial Carcinoma Survival. Ann Surg Oncol 2012 ; 19:3613–3620.

- AA Berod, P Colin, DR Yates, A Ouzzane, M Audouin, E Adam, F Arroua, C Marchand, P Bigot, M Soulié, M Roumiguié, T Polguer, S Gardic, P Grès, E Ravier, Y Neuzillet, F Delage, T Bodin, G Pignot, M Rouprêt : The role of American Society of Anesthesiologists scores in predicting urothelial carcinoma of the upper urinary tract outcome after radical nephroureterectomy: results from a national multi-institutional collaborative study. BJU Int 2012 Dec;110(11 Pt C):E1035-40.

- A Sufana Iancu, P Colin, P Puech, A Villers, A Ouzzane, JC Fantoni, X Leroy, L Lemaitre : Significance of ADC value for detection and characterization of urothelial carcinoma of upper urinary tract
using diffusion-weighted MRI. World J Urol 2013 Feb;31(1):13-9.

- M Vershasselt-Crinquette, P Colin, A Ouzzane, V Gnemmi, YM Robin, S Aubert, A Villers, X Leroy : Assessment of human epidermal growth factor receptor 2 status in urothelial carcinoma of the upper urinary tract: a study using dual-color in situ hybridization and immunohistochemistry. Appl Immunohistochem Mol Morphol 2012 Jul; 20(4):363-6.

- Audenet F, Colin P, Yates DR, Ouzzane A, Pignot G, Long JA, Soulie M, Phé V, Bensadoun H, Guy L, Ruffion A, Valeri A, Cormier L, Droupy S, de La Taille A, Saint F, Faïs PO, Houlgatte A, Cussenot O, Rouprêt M : A proportion of hereditary upper urinary tract urothelial carcinomas are misclassified as sporadic according to a multi-institutional database analysis: proposal of patient-specific risk identification tool. BJU Int 2012 Dec;110(11 Pt B):E583-9.

- Bozzini G, Colin P, Betrouni N, Nevoux P, Ouzzane A, Puech P, Villers A, Mordon S : Photodynamic therapy in urology: What can we do now and where are we heading? Photodiagnosis Photodyn Ther 2012 Sep; 9(3):261-73.

- Colin P, Mordon S, Nevoux P, Marqa MF, Ouzzane A, Puech P, Bozzini G, Leroux B, Villers A, Betrouni N : Focal laser ablation of prostate cancer: definition, needs, and future. Adv Urol 2012:589160.

- Yates DR, Hupertan V, Colin P, Ouzzane A, Descazeaud A, Long JA, Pignot G, Crouzet S, Rozet F, Neuzillet Y, Soulie M, Bodin T, Valeri A, Cussenot O, Rouprêt M : Cancer-specific survival after radical nephroureterectomy for upper urinary tract urothelial carcinoma: proposal and multi-institutional validation of a post-operative nomogram. Br J Cancer 2012 Mar 13; 106(6):1083-8.

- A Villers, F Marliere, A Ouzzane, P Puech, L Lemaître : MRI in addition to or as a substitute for prostate biopsy: the clinician's point of view. Diagn Interv Imaging 2012 Apr;93(4):262-7.

- P Colin, A Ouzzane, G Pignot, E Ravier, S Crouzet, MM Ariane, JN Cornu, M Audouin, Y Neuzillet, B Albouy, S Hurel, F Saint, J Guillotreau, L Guy, P Bigot, A De La Taille, F Arroua, C Marchand, A Matte, PO Fais, N Brichart, M Rouprêt : Comparison of Oncologic Outcomes after Segmental Ureterectmy or Radical Nephroureterectomy in Urothelial Carcinomas of the Upper Urinary Tract: Results from a large French Multicentric Study. BJU int, 2012 Oct; 110(8):1134-1141.

- G Bozzini, L Nison, P Colin, A Ouzzane, DR Yates, F Audenet, G Pignot, A Arvin-Berod, O Merigot, L Guy, J Irani, F Saint, S Gardic, P Gres, F Rozet, Y Neuzillet, A Ruffion, M Rouprêt : Influence of preoperative hydronephrosis on the outcome of urothelial carcinoma of the upper urinary tract after nephroureterectomy: the results from a multi-institutional French cohort. World J Urol 2013 Feb;31(1):83-91.

- L Nison, M Rouprêt, G Bozzini, A Ouzzane, F Audenet, G Pignot, A Ruffion, JN Cornu, S Hurel, A Valeri, M Roumiguie, T Polguer, N Hoarau, O Mérigot de Treigny, E Xylinas, A Matte, S Droupy, PO Fais, A Descazeaud, P Colin : The oncologic impact of a delay between diagnosis and radical nephroureterectomy due to diagnostic ureteroscopy in upper urinary tract urothelial carcinomas: results from a large collaborative database. World J Urol 2013 Feb;31(1):69-76.

- M Rouprêt, V Hupertan, T Seisen, P Colin, E Xylinas, DR Yates, H Fajkovic, Y Lotan, JD Raman, R Zigeuner, M Remzi, C Bolenz, G Novara, W Kassouf, A Ouzzane, F Rozet, O Cussenot, JI Martinez-Salamanca, HM Fritsche, TJ Walton, CG Wood, K Bensalah, PI Karakiewicz, F Montorsi, V Margulis, SF Shariat : Prediction of cancer specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized postoperative nomogram using decision curve analysis. J Urol. 2013 May;189(5):1662-9.

- A Ouzzane, P Colin, TP Ghoneim, M Zerbib, A De La Taille, F Audenet, F Saint, N Hoarau, E Adam, MD Azemar, H Bensadoun, L Cormier, O Cussenot, A Houlgatte, G Karsenty, C Maurin, FX Nouhaud, V Phe, T Polguer, M Roumiguié, A Ruffion, Rouprêt : The impact of lymph node status and features on oncological outcomes in urothelial carcinoma of the upper urinary tract (UTUC) treated by nephroureterectomy. World J Urol. 2013 Feb;31(1):189-97.

- P Puech, O Rouvière, R Renard-Penna, A Villers, P Devos, M Colombel, MO Bitker, X Leroy, F Mège-Lechevallier, E Comperat, A Ouzzane , L Lemaitre : Prostate Cancer Diagnosis: Multiparametric MR-targeted Biopsy with Cognitive and Transrectal US-MR Fusion Guidance versus Systematic Biopsy-Prospective Multicenter Study. Radiology. 2013 Aug;268(2):461-9.

- S Hurel, M Rouprêt, A Ouzzane, F Rozet, E Xylinas, M Zerbib, AA Berod, A Ruffion, E Adam, O Cussenot, A Houlgatte, V Phé, FX Nouhaud, H Bensadoun, F Delage, J Guillotreau, L Guy, G Karsenty, A De La Taille, P Colin : Impact of lymphovascular invasion on oncological outcomes in patients with upper tract urothelial carcinoma after radical nephroureterectomy. BJU Int. 2013 Jun;111(8):1199-207.

- G Fromont, F Rozet, X Cathelineau, A Ouzzane, L Doucet, G Fournier, O Cussenot : BCAR1 expression improves prediction of biochemical reccurence after radical prostatectomy. Prostate. 2012 Sep 1 ;72(12) :1359-65.

- A Ouzzane, F Rozet, R Sanchez Salas, M Galiano, E Barret, D Prapotnich, X Cathelineau : Positive Surgical Margins After Minimally Invasive Radical Prostatectomy in pT2 and pT3a Population Could be Considered as Pathological Upstaging. BJU Int 2014 Apr;113(4):586-91.

- C Hollande, P Colin, T de La Motte Rouge, F Audenet, DR Yates, V Phé, A Ouzzane, S Droupy, A Ruffion, A de La Taille, L Guy, O Cussenot, F Rozet, E Xylinas, M Zerbib, JP Spano, D Khayat, MO Bitker, M Rouprêt : Hereditary-like urothelial carcinoma of the upper urinary tract benefit more from adjuvant cisplatin-based chemotherapy after radical nephroureterectomy than do sporadic tumours. BJU int 2014 Apr;113(4):574-80.

- A Forgues, F Rozet, F Audenet, A Ouzzane, R Sanchez-Salas, E Barret, M Galiano, D Prapotnich, X Cathelineau : Oncologic outcomes after minimally invasive radical prostatectomy in patients with seminal vesicle invasion (pT3b) without adjuvant therapy. World J Urol 2014 Apr;32(2):519-24.

- P Colin, TP Ghoneim, L Nison, T Seisen, E Lechevallier, X Cathelineau, A Ouzzane, M Zerbib, JA Long, A Ruffion, S Crouzet, O Cussenot, M Audouin, J Irani, S Gardic, P Gres, F Audenet, M Roumiguié, A Valeri, M Rouprêt : Risk stratification of metastatic recurrence in invasive upper urinary tract carcinoma after radical nephroureterectomy without lymphadenectomy. World J Urol 2014 Apr;32(2):507-12.

- G Ploussard, F Staerman, J Pierrevelcin, S Larue, A Villers, A Ouzzane, C Bastide, N Gaschignard, F Buge, C Pfister, R Bonniol, X Rebillard, S Fadli, N Mottet, F Saint, R Saad, JB Beauval, M Roupret, F Audenet, M Peyromaure, NB Delongchamps, S Vincendeau, T Fardoun, J Rigaud, M Soulie, L Salomon. Clinical outcomes after salvage radiotherapy without androgen deprivation therapy in patients with persistently detectable PSA after radical prostatectomy: results from a national multicentre study. World J Urol 2014 Oct;32(5):1331-8.

- A Ouzzane, P Colin. Bladder cancer: Tumour recurrence after radical nephroureterectomy for UTUC. Nat Rev Urol 2014 Jan;11(1):15-6.

- A Ouzzane, Puech P, Villers A. How accurately can MRI detect indolent disease? Curr Opin Urol 2014 May;24(3):264-9.

- F Marliere, P Puech, A Benkirane, A Villers, L Lemaitre, X Leroy, N Betrouni, A Ouzzane. The role of MRI-targeted and confirmatory biopsies for cancer upstaging at selection in patients considered for active surveillance for clinically low-risk prostate cancer. World J Urol 2014 Aug;32(4):951-8.

- J Kaouk, GP Haber, R Autorino, S Crouzet, A Ouzzane, V Flamand, A Villers. A Novel Robotic System for Single-port Urologic Surgery: First Clinical Investigation. Eur Urol 2014 Dec;66(6):1033-43.

- P Puech, A Villers, A Ouzzane, L Lemaitre. Prostate cancer: diagnosis, parametric imaging and standardized report. Diagn Interv Imaging 2014 Jul-Aug;95(7-8):743-52.

- O Chilali, A Ouzzane, M Diaf, N Betrouni. A survey of prostate modeling for image analysis. Comput Biol Med 2014 Oct;53:190-202.

- S Hurel, M Rouprêt, T Seisen, E Comperat, V Phé, S Droupy, F Audenet, G Pignot, X Cathelineau, L Guy, O Cussenot, A Ouzzane, G Bozzini, L Nison, A Ruffion, P Colin. Influence of preoperative factors on the oncologic outcome for upper urinary tract urothelial carcinoma after radical nephroureterectomy. World J Urol 2015 Mar;33(3):335-41.

- P Puech, A Ouzzane, V Gaillard, N Betrouni, B Renard, A Villers, L Lemaitre. Multiparametric MRI-targeted TRUS prostate biopsies using visual registration. Biomed Res Int 2014:819360.

- Y Bayoud, A de la Taille, A Ouzzane, G Ploussard, Y Allory, R Yiou, D Vordos, A Hoznek , L Salomon : International Prostate Symptom Score is a predictive factor of lower urinary tract symptoms after radical prostatectomy. Int J Urol 2015 Mar;22(3):283-7.

- A Ouzzane, O Helfrich, J Le Nobin, P Puech, A Villers : Understanding the pathological implications of MRI: application to focal therapy planning. Curr Opin Urol. 2015 May;25(3):198-204.

- A Ouzzane , R Renard-Penna , F Marliere , P Mozer , J Olivier , J Barkatz , P Puech, A Villers : MRI-Targeted Biopsy Improves Selection of Patients Considered for Active Surveillance for Clinically Low-Risk Prostate Cancer Based on Systematic Biopsies. J Urol. 2015 Aug;194(2):350-6.

- Puech P, Randazzo M, Ouzzane A, Gaillard V, Rastinehad A, Lemaitre L, Villers A : How are we going to train a generation of radiologists (and urologists) to read prostate MRI? Curr Opin Urol 2015 Nov;25(6):522-35.

- Azahaf M, Haberley M, Betrouni N, Ernst O, Behal H, Duhamel A, Ouzzane A, Puech P. Impact of arterial input function selection on the accuracy of dynamic contrast-enhanced MRI quantitative analysis for the diagnosis of clinically significant prostate cancer. J Magn Reson Imaging. 2016 Mar;43(3):737-49.

- Moore CM, Giganti F, Albertsen P, Allen C, Bangma C, Briganti A, Carroll P, Haider M, Kasivisvanathan V, Kirkham A, Klotz L, Ouzzane A, Padhani AR, Panebianco V, Pinto P, Puech P, Rannikko A, Renard-Penna R, Touijera K, Turkbey B, van Poppel H, Valdagni R, Walz J, Schoots I. Reporting Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer: The PRECISE Recommendations-A Report of a European School of Oncology Task Force. Eur Urol. 2016 Jun 24. pii: S0302-2838(16)30281-0.

- Villers A, Puech P, Flamand V, Haber GP, Desai MM, Crouzet S, Leroy X, Chopra S, Lemaitre L, Ouzzane A, Gill IS. Partial Prostatectomy for Anterior Cancer: Short-term Oncologic and Functional Outcomes. Eur Urol. 2016 Sep 6. pii: S0302-2838(16)30530-9.

- A Ouzzane, N Betrouni, M Valerio, P Colin and G Ploussard. Focal Therapy as Primary Treatment for Localised Prostate Cancer: Definition, Needs, and Future. Future Oncol. 2016 in press.

- Helfrich O, Puech P, Betrouni N, Pinçon C, Ouzzane A, Rizk J, Marcq G, Randazzo M, Durand M, Lakroum S, Leroy X, Villers A. Quantified analysis of histological components and architectural patterns of gleason grades in apparent diffusion coefficient restricted areas upon diffusion weighted MRI for peripheral or transition zone cancer locations. J Magn Reson Imaging 2017 in press

- Beauval JB, Cabarrou B, Gandaglia G, Patard PM, Ouzzane A, de la Taille A, Soulié M, Briganti A, Ploussard G, Rozet F, Roumiguié M. External validation of a nomogram for identification of pathologically favorable disease in intermediate risk prostate cancer patients. Prostate. 2017 Jun;77(8):928-933.

- Beauval JB, Ploussard G, Cabarrou B, Roumiguié M, Ouzzane A, Gas J, Goujon A, Marcq G, Mathieu R, Vincendeau S, Cathelineau X, Mongiat-Artus P, Salomon L, Soulié M, Méjean A, de La Taille A, Rouprêt M, Rozet F; Committee of Cancerology of the Association of French Urology. Improved decision making in intermediate-risk prostate cancer: a multicenter study on pathologic and oncologic outcomes after radical prostatectomy. World J Urol. 2017 in press.

- Villers A, Flamand V, Arquímedes RC, Puech P, Haber GP, Desai MM, Crouzet S, Ouzzane A, Gill IS. Robot-assisted partial prostatectomy for anterior prostate cancer: a step-by-step guide. BJU Int. 2017 Jun;119(6):968-974.

- A Ouzzane, P Koenig, C Ballereau, T Ghoneim, L Zini, JC Fantoni, J Biserte, A Villers : Résultats oncologiques après prostatectomie totale pour cancer : validation française de la classification de D’Amico. Prog Urol, 2010 Dec ;20(13): 1206—1212.

- A Ouzzane, P Coloby, JP Mignard, JP Allegre, M Soulie, X Rebillard, L Salomon, A Villers : Recommandations pour la bonne pratique des biopsies prostatiques. Prog Urol, 2010 : 21(1):18-28.

- P Colin, JP Estevez, N Betrouni, A Ouzzane, P Puech, X Leroy, J Biserte, A Villers, S Mordon : Thérapie photodynamique dans le cancer de la prostate. Prog Urol, 2011 : 21(2):85-92.

- P Colin, M Verhasselt-Crinquette, A Ouzzane, R Yakoubi, C Bouchery, S Debrock, JC Fantoni, A Villers, X Leroy : Rôle pronostique des emboles vasculaires tumoraux dans les tumeurs des voies excrétrices urinaires supérieures : analyse rétrospective monocentrique. Prog Urol 2010 May; 22(6):331-8.

- A Broucqsault, A Ouzzane, D Launay, X Leroy, C Rose, A Villers, JC Fantoni : Hématopoïèse extra-médullaire rénale. Prog Urol, 2011 Sep;21(8):575-9.

- TP Ghoneim, A Ouzzane, X Leroy, L Lemaitre, JC Fantoni, A Villers, L Zini : Le carcinome a cellules rénales du sujet de moins de 40 ans. Prog Urol, 2012 Feb;22(2):93-9.

- A Broucqsault, A Ouzzane, X Leroy, L Lemaitre, L Zini : Cancer du rein de moins de 4 cm : traitement dans un centre de référence régional en cancérologie. Prog Urol 2012 Oct;22(12):692-700.

- A Ouzzane, M Rouprêt, P Leon, DR Yates, P Colin : Épidémiologie et facteurs de risque des tumeurs de la voie excrétrice urinaire supérieure : revue de la littérature pour le rapport annuel de l’Association française d’urologie. Prog Urol 2014 Nov;24(15):966-76.

- J Rizk, A Ouzzane, V Flamand, JC Fantoni, P Puech, X Leroy, A Villers : Survie sans récidive biologique à long terme après prostatectomie totale pour cancer : analyse comparative selon la voie d’abord et le stade clinico-pathologique. Prog Urol 2015 Mar;25(3):157-168.

- P Vandaele, F Marcelli, A Ouzzane, P Puech, A Villers, JM Rigot. Nodules testiculaires de l’homme infertile et échographie de contraste : étude préliminaire. Prog Urol 2015 Apr;25(5):274-81.

- F Maillard, S Manouvrier, X Biardeau, A Ouzzane, A Villers : Syndrome de Lynch et risque de cancer de la prostate : revue de la littérature. Prog Urol 2015 Apr;25(5):225-32.

- Khodari M, Ouzzane A, Marcelli F, Yakoubi R, Mitchell V, Zerbib P, Rigot JM. Azoospermie et antécédent de cure de hernie inguinale chez l’adulte. Prog Urol 2015 Oct;25(12):692-7.

- Hénon F, Le Nobin J, Ouzzane A, Villers A, Strecker G, Bouyé S. Analyse des raisons motivant le refus du don d’organes par les familles de patients en état de mort encéphalique dans un centre régional de prélèvement. Prog Urol 2016 Sep - Oct;26(11-12):656-661.

- F. Rozet, C. Hennequin, J.-B. Beauval, P. Beuzeboc, L. Cormier, G. Fromont, P. Mongiat-Artus, A. Ouzzane, G. Ploussard, D. Azria, I. Brenot-Rossi, G. Cancel-Tassin, O. Cussenot, X. Rebillard, M. Soulié, R. Renard-Penna, A. Mejean. Recommandations du CCAFU – Cancer de la prostate : Actualisation 2016. Prog Urol 2016 Nov;27 Suppl 1:S95-S143.

- Vidmar R, Marcq G, Flamand V, Fantoni JC, Hénon F, Villers A, Ouzzane A. Prostatectomie totale de rattrapage après échec de traitement local pour cancer de prostate : morbidité, résultats oncologiques et fonctionnels. Prog Urol. 2017 Jun - Jul;27(8-9):458-466.

- Raichi A, Marcq M, Fantoni JC, Puech P, Villers A, Ouzzane A. Surveillance active dans le cancer de prostate : évaluation de l’IRM dans la sélection et le suivi des patients. Prog Urol. 2017 sous presse.

- Martin-Malburet A, Marcq G, Leroy X, Guiffart P, Fantoni JC, Flamand V, Villers A, Puech P, et Ouzzane A. Résultats anatomopathologiques après prostatectomie totale pour cancer chez des patients éligibles à une surveillance active : apport de l’IRM multiparamétrique dans la décision de traitement. Prog Urol. 2017 sous presse.

- A Ouzzane, A Villers : The role of imaging in suspected prostate cancer. European Urological review 2011, Volume 6, Issue 2, Pages 124-127 ;

- D Lizée, A Ouzzane, A Villers : Cancer de la prostate : diagnostic et bilan d’extension. Encyclopédie médico-chirurgicale 2012, 18-560-A.

- A Ouzzane, P Nevoux, P Colin, A Villers : Bases histopathologiques pour la thérapie focale dans le cancer localisé de la prostate. Progrès en Urologie FMC. Septembre 2010, Vol 20 - N°3 – page F96.

- G Bozzini, P Colin, A Ouzzane, A Villers : Émergence des thérapies focales du cancer localisé de la prostate. Rev Prat 2013 Apr;63(4):489-93.

- A Ouzzane, V Flamand, R Yakoubi, J-C Fantoni, X Leroy et J Le Nobin. Néphrectomie partielle ou totale pour les carcinomes à cellules rénales de haut grade de Führman. Clinical Urology 2016 Sep ;(14) :772-784.

- A Villers, A Ouzzane : Multimodality MRI-guided Targeting. Springer Hardback book chapter “Imaging and Focal Therapy of Early Stage Prostate Cancer”, 2012 pages 133-140.

- A Ouzzane, P Colin, N Betrouni, A Villers : Failure or Recurrence Management. Springer book chapter “FOCAL THERAPY IN LOCALIZED PROSTATE CANCER”, 2015 pages 209-214.

Icon